Twist

Barfresh Provides Fourth Quarter and Full Year 2023 Results and Business Update

Retrieved on: 
Thursday, February 29, 2024

LOS ANGELES, Feb. 29, 2024 (GLOBE NEWSWIRE) -- Barfresh Food Group Inc. (the “Company” or “Barfresh”) (Nasdaq: BRFH), a provider of frozen, ready-to-blend and ready-to-drink beverages, is providing a business update for the full year ended December 31, 2023.

Key Points: 
  • Gross margins for the fourth quarter of 2023 were 33%, compared to 36% for the fourth quarter of fiscal year 2022.
  • Net loss for the fourth quarter of 2023 was $701,000, as compared to a loss of $1.9 million in the fourth quarter of 2022.
  • Selling, marketing and distribution for the fourth quarter of 2023 was $624,000, compared to $625,000 in the fourth quarter of 2022.
  • G&A expenses for the fourth quarter of 2023 decreased 31% to $629,000 compared to $912,000 in the fourth quarter of 2022.

Twist Bioscience Launches IVDR-compliant Precision Dx Products for Whole Exome Sequencing

Retrieved on: 
Tuesday, March 5, 2024

The suite of our CE-marked Products includes:

Key Points: 
  • The suite of our CE-marked Products includes:
    The Twist Precision Prep and Enrichment Dx Kit1 (Reagents for enzymatic fragmentation, library preparation, and target enrichment), which is panel-agnostic2
    Twist Precision Exome Dx Kit1 (Reagents for enzymatic fragmentation, library preparation, and target enrichment along with targeted capture probes for exome enrichment; IVDR compliant workflow)
    The Twist Precision Prep and Enrichment Dx Kit and the Twist Precision Exome Dx Panel can be used individually within existing workflows or as a combined solution known as the Twist Precision Exome Dx Kit.
  • “The Twist Precision Dx products are our first NGS product line specifically developed to be included within regulated customer products.
  • The Twist Precision Exome Dx Panel1 is a qualified Twist DNA panel that can be used in conjunction with the Twist Precision Prep and Enrichment Dx kit to produce exome-enriched libraries compatible for NGS applications.
  • Twist Precision Exome Dx Kit1 utilizes the qualified Twist Precision Exome Dx Panel along with the Twist Precision Prep and Enrichment Dx Kit to produce exome-enriched libraries compatible for NGS applications.

Insightly to Live Stream Relationship Marketing Happy Hour Featuring Best-selling Author Jay Baer and TC Craft Tequila

Retrieved on: 
Wednesday, February 28, 2024

SAN DIEGO, Feb. 28, 2024 /PRNewswire-PRWeb/ -- Insightly, the modern, affordable CRM teams love, is hosting its first live stream happy hour event on Wednesday, March 6 at 5 p.m. ET. Insightly's Senior Director of Content and Digital Marketing, Val Riley, will host the event alongside Chief Marketing Officer Chip House. Jay Baer, business advisor, best-selling author, and tequila influencer will lead the discussion on tactics for go-to-market teams to cultivate customer advocacy to feed the marketing funnel.

Key Points: 
  • Creating Brand Champions…with a Twist
    SAN DIEGO, Feb. 28, 2024 /PRNewswire-PRWeb/ -- Insightly , the modern, affordable CRM teams love, is hosting its first live stream happy hour event on Wednesday, March 6 at 5 p.m.
  • Insightly's Senior Director of Content and Digital Marketing, Val Riley , will host the event alongside Chief Marketing Officer Chip House.
  • Jay Baer , business advisor, best-selling author, and tequila influencer will lead the discussion on tactics for go-to-market teams to cultivate customer advocacy to feed the marketing funnel.
  • The event will conclude with a fun cocktail-making experience featuring TC Craft Tequila and a chance to win a prize pack from the brand.

Dutch Boy® Paints Enhances Porch and Floor Paint Collection

Retrieved on: 
Thursday, February 15, 2024

CLEVELAND, Feb. 15, 2024 /PRNewswire/ -- As homeowners explore innovative ways of elevating their home, Dutch Boy® Paints unveils the latest update to its product lineup—a next-generation Porch and Floor Paint + Primer. Whether it's porches, basements or breezeways, Dutch Boy® Paints' Porch and Floor Paint + Primer is a simple, cost-effective solution for DIYers looking to enhance and protect indoor and outdoor living spaces.

Key Points: 
  • The new formulas are an evolution of Dutch Boy® Paints' currently acclaimed Porch and Floor Paint + Primer products.
  • The enhanced Dutch Boy® Paints Porch and Floor Paint + Primer line features both a standard porch and floor paint, as well as a skid-resistant option, providing added traction.
  • Dutch Boy® Paints' Porch and Floor Paint + Primer is tintable to all Dutch Boy® paint colors and can be color-matched, allowing for customization and personalization.
  • Visit Porch & Floor Paint + Primer | Dutch Boy or Menards retail locations to explore the full collection.

Twist Bioscience Launches cfDNA Library Preparation Kit for Liquid Biopsy Applications

Retrieved on: 
Tuesday, February 6, 2024

The Twist cfDNA Library Preparation Kit was purpose-built to maximize the number of unique cfDNA molecules that are captured in library preparation, for higher confidence in the accuracy and sensitivity of liquid biopsy tests.

Key Points: 
  • The Twist cfDNA Library Preparation Kit was purpose-built to maximize the number of unique cfDNA molecules that are captured in library preparation, for higher confidence in the accuracy and sensitivity of liquid biopsy tests.
  • With exceptional accuracy and sensitivity enabled by high conversion rates, the Twist cfDNA Library Preparation Kit can help push the limit of detection and detect lower frequency variants that can be missed by other on market library preparation solutions.”
    The Twist cfDNA Library Preparation Kit adds to Twist’s growing portfolio of tools to support the research and development of liquid biopsy assays, which also includes the recently launched Twist cfDNA Pan-Cancer Reference Standard v2 .
  • The Twist cfDNA Library Preparation Kit can address challenges associated with library preparation from circulating cfDNA with reliable and robust performance from as little as 1ng sample input.
  • The Twist cfDNA Library Preparation Kits are available in two configurations: the cfDNA Library Preparation Kit for whole genome sequencing (WGS) workflows and the Twist Library Preparation and Hyb Mix Kit for target enrichment.

Twist Bioscience Unveils Differentiated Ultra High-Throughput Library Preparation Solution at AGBT

Retrieved on: 
Monday, February 5, 2024

Built upon enzymatic fragmentation library preparation, the Twist Flex Prep UHT Kit utilizes novel chemistry that accepts and self-normalizes a wide range of sample input amounts through a new proprietary Normalization By Ligation (NBL) technology.

Key Points: 
  • Built upon enzymatic fragmentation library preparation, the Twist Flex Prep UHT Kit utilizes novel chemistry that accepts and self-normalizes a wide range of sample input amounts through a new proprietary Normalization By Ligation (NBL) technology.
  • The enhanced multiplexing further limits hands on time and saves researchers costs of reagents in downstream purification and indexing steps.
  • Twist will highlight its NGS tools in posters and presentations at the AGBT General Meeting taking place in Orlando, FL February 5-8, 2024.
  • Details are as follows:
    Poster: Twist Pan-Cancer Reference Standards V2: Enhanced Precision and Reduced Errors in ctDNA Analysis

Twist Bioscience Reports Fiscal First Quarter 2024 Financial Results

Retrieved on: 
Friday, February 2, 2024

Orders: Total orders received for the first quarter of fiscal 2024 increased to $77.5 million compared to $64.7 million for the same period of fiscal 2023.

Key Points: 
  • Orders: Total orders received for the first quarter of fiscal 2024 increased to $77.5 million compared to $64.7 million for the same period of fiscal 2023.
  • Revenue: Total revenues for the first quarter of fiscal 2024 increased to $71.5 million compared to $54.2 million for the same period of fiscal 2023.
  • Shipped approximately 171,000 genes during the first quarter of fiscal 2024, compared with approximately 134,000 genes during the first quarter of fiscal 2023.
  • The following statements are based on Twist’s current expectations for fiscal 2024, including the second quarter of fiscal 2024.

Painting with a Twist Ranks No. 1 In Entrepreneur Franchise 500 Category and Celebrates Systemwide Growth in 2024

Retrieved on: 
Tuesday, January 16, 2024

NEW ORLEANS, Jan. 16, 2024 /PRNewswire/ -- Painting with a Twist, the nation's dominating paint and sip brand, has been named the No. 1 DIY/Paint-&-Sip Studio in Entrepreneur's Franchise 500®, the world's first, best and most comprehensive franchise ranking. This highly sought-after honor in the franchise industry ranks brands on outstanding performance in areas including unit growth, financial strength and stability and brand power. Painting with a Twist dominating the category comes as no surprise after the brand has seen impressive growth throughout the previous year, driven by its commitment to innovate exciting new opportunities to its guests.

Key Points: 
  • 1 DIY/Paint-&-Sip Studio in Entrepreneur's Franchise 500®, the world's first, best and most comprehensive franchise ranking.
  • This highly sought-after honor in the franchise industry ranks brands on outstanding performance in areas including unit growth, financial strength and stability and brand power.
  • Painting with a Twist dominating the category comes as no surprise after the brand has seen impressive growth throughout the previous year, driven by its commitment to innovate exciting new opportunities to its guests.
  • In addition to being top in its category, Painting with a Twist was listed in the overall Entrepreneur Franchise 500 ranking.

Twist Bioscience Appoints Adam Laponis as Chief Financial Officer

Retrieved on: 
Friday, January 5, 2024

Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced the appointment of Adam Laponis as chief financial officer.

Key Points: 
  • Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced the appointment of Adam Laponis as chief financial officer.
  • Mr. Laponis brings experience across small cap and Fortune 50 companies along with a track record of collaborating across teams to drive profitable growth.
  • View the full release here: https://www.businesswire.com/news/home/20240105333128/en/
    Adam Laponis, chief financial officer of Twist Bioscience (Photo: Business Wire)
    “Adam’s deep financial acumen and strategic planning expertise across diverse businesses make him an ideal fit for our next phase of growth,” said Emily M. Leproust, Ph.D., CEO and co-founder of Twist Bioscience.
  • Previously, Mr. Laponis served as vice president, finance and chief financial officer, cardiovascular care at Cardinal Health as the finance leader for the worldwide Cordis Cardiovascular business.

Twist Bioscience Reports Fiscal Fourth Quarter and Full Year Fiscal 2023 Financial Results

Retrieved on: 
Friday, November 17, 2023

Revenue: Total revenues for fiscal 2023 grew to $245.1 million compared to $203.6 million for fiscal 2022.

Key Points: 
  • Revenue: Total revenues for fiscal 2023 grew to $245.1 million compared to $203.6 million for fiscal 2022.
  • Cost of Revenues: Cost of revenues for fiscal 2023 grew to $155.4 million compared to $119.3 million for fiscal 2022.
  • Orders: Total orders received for the fourth quarter of fiscal 2023 grew to $71.1 million compared to $62.1 million for the same period of fiscal 2022.
  • Revenue: Total revenues for the fourth quarter of fiscal 2023 grew to $66.9 million compared to $57.3 million for the same period of fiscal 2022.